Combination Of Sildenafil To Bosentan Therapy In Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Defects

被引:0
|
作者
Beciani, E.
Leci, E.
Palazzini, M.
Bachetti, C.
Sciarra, F.
Conficoni, E.
Manes, A.
Galie, N.
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5895
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Combination therapy with bosentan and sildenafil compared with bosentan alone in patients with pulmonary arterial hypertension
    Al-Sharif, Hassan
    Bshouty, Zoheir
    [J]. CHEST, 2006, 130 (04) : 255S - 256S
  • [2] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O.
    Beghetti, M.
    Petit, J.
    Iserin, L.
    Humbert, M.
    Gressin, V.
    Simonneau, G.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 25 - 31
  • [3] Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension
    Hoeper, MM
    Faulenbach, C
    Golpon, H
    Winkler, J
    Welte, T
    Niedermeyer, J
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (06) : 1007 - 1010
  • [4] Metformin added to bosentan therapy in patients with pulmonary arterial hypertension associated with congenital heart defects: a pilot study
    Liao, Shutan
    Li, Dongsheng
    Hui, Zheng
    McLachlan, Craig S.
    Zhang, Yang
    [J]. ERJ OPEN RESEARCH, 2018, 4 (03)
  • [5] Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
    McLaughlin, Vallerie
    Channick, Richard N.
    Ghofrani, Hossein-Ardeschir
    Lemarie, Jean-Christophe
    Naeije, Robert
    Packer, Milton
    Souza, Rogerio
    Tapson, Victor F.
    Tolson, Jonathan
    Al Hiti, Hikmet
    Meyer, Gisela
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (02) : 405 - 413
  • [6] Treatment of Patients with Severe Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease with Bosentan and Sildenafil
    Zhu, Xianyang
    Zhang, Duanzhen
    Meng, Jing
    Sheng, Xiaotang
    [J]. CIRCULATION, 2010, 122 (02) : E238 - E238
  • [7] Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
    Verlinden, Nathan J.
    Benza, Raymond L.
    Raina, Amresh
    [J]. PULMONARY CIRCULATION, 2020, 10 (04)
  • [8] First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension
    Lunze, K.
    Gilbert, N.
    Mebus, S.
    Miera, O.
    Fehske, W.
    Uhlemann, F.
    Muehler, E. G.
    Ewert, P.
    Lange, P. E.
    Berger, F.
    Schulze-Neick, I.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 32 - 38
  • [9] The addition of sildenafil to bosentan therapy in the treatment of pulmonary arterial hypertension
    Mathai, SC
    Fisher, MR
    Housten-Harris, T
    Girgis, RE
    Hassoun, PM
    [J]. CHEST, 2005, 128 (04) : 161S - 162S
  • [10] The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O
    Beghetti, M
    Petit, J
    Iserin, L
    Humbert, M
    Gressin, V
    Simonneau, G
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 22 - 22